Neimeth International Pharmaceuticals Plc (NGX:NEIMETH)

NGX:NEIMETH Ratios and Metrics

Market cap in millions NGN. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021
Period Ending	Jan 20, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Sep 30, 2022	Sep 30, 2021
Market Capitalization	57,260	9,785	8,290	2,716	2,659	3,324
Market Cap Growth	541.15%	18.04%	205.24%	2.14%	-20.00%	-5.41%
Enterprise Value	60,382	11,901	9,264	5,237	4,683	5,412
Last Close Price	13.40	2.29	1.94	1.43	1.40	1.68
PE Ratio	-	-	-	-	-	12.28
PS Ratio	8.95	2.18	3.75	0.93	0.98	1.09
PB Ratio	28.75	5.92	3.27	3.49	2.43	2.35
P/TBV Ratio	28.92	5.99	3.27	3.49	2.43	2.35
P/FCF Ratio	67.88	-	-	-	-	1693.09
P/OCF Ratio	44.74	24.70	-	20.49	-	9.61
EV/Sales Ratio	9.43	2.65	4.19	1.79	1.73	1.78
EV/EBITDA Ratio	21.87	6.07	21.81	54.54	49.41	8.47
EV/EBIT Ratio	23.11	6.50	31.01	-	-	9.86
EV/FCF Ratio	71.58	-	-	-	-	2756.94
Debt / Equity Ratio	2.65	3.26	1.73	4.68	3.05	2.15
Debt / EBITDA Ratio	1.91	2.74	10.33	35.20	35.15	4.64
Debt / FCF Ratio	6.26	-	-	-	-	1551.72
Asset Turnover	0.56	0.41	0.27	-	0.43	0.48
Inventory Turnover	1.09	1.19	0.79	-	1.02	1.12
Quick Ratio	0.28	0.35	0.45	0.48	0.63	1.53
Current Ratio	0.66	0.58	0.76	1.00	1.24	2.28
Return on Equity (ROE)	-45.40%	-42.27%	-108.42%	-	-8.74%	20.13%
Return on Assets (ROA)	14.18%	10.33%	2.24%	-	-0.24%	5.41%
Return on Invested Capital (ROIC)	50.72%	39.03%	7.05%	-0.33%	-0.82%	18.60%
Return on Capital Employed (ROCE)	105.00%	85.50%	9.80%	-0.40%	-0.80%	13.20%
Earnings Yield	-1.50%	-9.05%	-21.68%	-11.97%	-4.12%	8.14%
FCF Yield	1.47%	-3.13%	-20.62%	-41.87%	-45.31%	0.06%
Dividend Yield	-	-	-	-	-	4.17%
Payout Ratio	-	-	-	-	-	45.62%
Buyback Yield / Dilution	-	-	-125.00%	-	-	-
Total Shareholder Return	-	-	-125.00%	-	-	4.17%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.